Acromegaly is characterized by an insulin resistance condition. There is a significant difference between the different types of therapy in relation to the glycometabolic framework. The blinded continuous glucose monitoring system (CGMS), throughout a period of maximum 6 days for a total of 288 glycemic registrations per day, identifies glycemic excursions and could constitute a valid device to understand the 24-hour glycemic profiles.
Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control / Mercuri, Valeria; D'Amico, Tania; Costa, Denise; De Vito, Corrado; D'Angelo, Luca; Schiaffini, Riccardo; Gargiulo, Patrizia. - In: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. - ISSN 1932-2968. - (2020), pp. 1-6. [10.1177/1932296820949882]
Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control
Mercuri, Valeria;D'Amico, Tania;Costa, Denise;De Vito, Corrado;Gargiulo, Patrizia
2020
Abstract
Acromegaly is characterized by an insulin resistance condition. There is a significant difference between the different types of therapy in relation to the glycometabolic framework. The blinded continuous glucose monitoring system (CGMS), throughout a period of maximum 6 days for a total of 288 glycemic registrations per day, identifies glycemic excursions and could constitute a valid device to understand the 24-hour glycemic profiles.| File | Dimensione | Formato | |
|---|---|---|---|
|
Mercuri_Continuous_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
215.79 kB
Formato
Adobe PDF
|
215.79 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
